Literature DB >> 22254414

Intracellular electroporation site distributions: modeling examples for nsPEF and IRE pulse waveforms.

T R Gowrishankar1, A T Esser, K C Smith, R S Son, J C Weaver.   

Abstract

We illustrate expected electroporation (EP) responses to two classes of large electric field pulses by employing systems models, one of a cell in vitro and the other of multiple cells in vivo. The first pulse class involves "nsPEF" (nanosecond pulsed electric fields). The durations are less than a microsecond, but the magnitudes are extremely large, often 10 kV/cm or more, and all of the pores remain small. The second class involves "IRE" (irreversible electroporation). Durations are many microseconds to several milliseconds, but with magnitudes smaller than 10 kV/cm, and a wide range of pore sizes evolves. A key feature of both pulse classes is non-thermal cell killing by multiple pulses without delivering external drugs or genes. For small pulses the models respond passively (no pore creation) providing negative controls. For larger pulses transient aqueous pore populations evolve. These greatly increase local membrane conductance temporarily, causing rapid redistribution of fields near and within cells. This complex electrical behavior is generally not revealed by experiments reporting biological end points resulting from cumulative ionic and molecular transport through cell membranes. The underlying, heterogeneous pore population distributions are also not obtained from typical experiments. Further, traditional EP applications involving molecular delivery are usually assumed to create pores solely in the outer, plasma membrane (PM). In contrast, our examples support the occurrence of intracellular EP by both nsPEF and IRE, but with different intracellular spatial distributions of EP sites.

Entities:  

Mesh:

Year:  2011        PMID: 22254414      PMCID: PMC3414423          DOI: 10.1109/IEMBS.2011.6090166

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  10 in total

1.  Intracellular effect of ultrashort electrical pulses.

Authors:  K H Schoenbach; S J Beebe; E S Buescher
Journal:  Bioelectromagnetics       Date:  2001-09       Impact factor: 2.010

2.  Mechanisms for the intracellular manipulation of organelles by conventional electroporation.

Authors:  Axel T Esser; Kyle C Smith; T R Gowrishankar; Zlatko Vasilkoski; James C Weaver
Journal:  Biophys J       Date:  2010-06-02       Impact factor: 4.033

3.  Tissue ablation with irreversible electroporation.

Authors:  R V Davalos; I L M Mir; B Rubinsky
Journal:  Ann Biomed Eng       Date:  2005-02       Impact factor: 3.934

4.  Cancer cells ablation with irreversible electroporation.

Authors:  Liron Miller; Jonathan Leor; Boris Rubinsky
Journal:  Technol Cancer Res Treat       Date:  2005-12

5.  Towards solid tumor treatment by irreversible electroporation: intrinsic redistribution of fields and currents in tissue.

Authors:  Axel T Esser; Kyle C Smith; Thiruvallur R Gowrishankar; James C Weaver
Journal:  Technol Cancer Res Treat       Date:  2007-08

6.  Optimized nanosecond pulsed electric field therapy can cause murine malignant melanomas to self-destruct with a single treatment.

Authors:  Richard Nuccitelli; Kevin Tran; Saleh Sheikh; Brian Athos; Mark Kreis; Pamela Nuccitelli
Journal:  Int J Cancer       Date:  2010-10-01       Impact factor: 7.396

7.  Towards solid tumor treatment by nanosecond pulsed electric fields.

Authors:  Alex T Esser; Kyle C Smith; T R Gowrishankar; James C Weaver
Journal:  Technol Cancer Res Treat       Date:  2009-08

8.  Successful treatment of a large soft tissue sarcoma with irreversible electroporation.

Authors:  Robert E Neal; John H Rossmeisl; Paulo A Garcia; Otto I Lanz; Natalia Henao-Guerrero; Rafael V Davalos
Journal:  J Clin Oncol       Date:  2011-02-14       Impact factor: 44.544

9.  In vitro and in vivo evaluation and a case report of intense nanosecond pulsed electric field as a local therapy for human malignancies.

Authors:  Edward B Garon; David Sawcer; P Thomas Vernier; Tao Tang; Yinghua Sun; Laura Marcu; Martin A Gundersen; H Phillip Koeffler
Journal:  Int J Cancer       Date:  2007-08-01       Impact factor: 7.396

10.  Tumor ablation with irreversible electroporation.

Authors:  Bassim Al-Sakere; Franck André; Claire Bernat; Elisabeth Connault; Paule Opolon; Rafael V Davalos; Boris Rubinsky; Lluis M Mir
Journal:  PLoS One       Date:  2007-11-07       Impact factor: 3.240

  10 in total
  6 in total

1.  Rapid dramatic alterations to the tumor microstructure in pancreatic cancer following irreversible electroporation ablation.

Authors:  Zhuoli Zhang; Weiguo Li; Daniel Procissi; Patrick Tyler; Reed A Omary; Andrew C Larson
Journal:  Nanomedicine (Lond)       Date:  2013-09-11       Impact factor: 5.307

Review 2.  A brief overview of electroporation pulse strength-duration space: a region where additional intracellular effects are expected.

Authors:  James C Weaver; Kyle C Smith; Axel T Esser; Reuben S Son; T R Gowrishankar
Journal:  Bioelectrochemistry       Date:  2012-03-14       Impact factor: 5.373

3.  Anti-tumor Efficacy Study using Irreversible Electroporation and Doxorubicin-loaded Polymeric Micelles.

Authors:  Jun Zhao; John Qiao; Min Zhou; Sanjay Gupta; Chun Li; Marites P Melancon
Journal:  ACS Macro Lett       Date:  2015-09-11       Impact factor: 6.903

4.  Nanosecond electric pulse effects on gene expression.

Authors:  Louise Chopinet; Tina Batista-Napotnik; Audrey Montigny; Matej Rebersek; Justin Teissié; Marie-Pierre Rols; Damijan Miklavčič
Journal:  J Membr Biol       Date:  2013-07-06       Impact factor: 1.843

5.  Basic features of a cell electroporation model: illustrative behavior for two very different pulses.

Authors:  Reuben S Son; Kyle C Smith; Thiruvallur R Gowrishankar; P Thomas Vernier; James C Weaver
Journal:  J Membr Biol       Date:  2014-07-22       Impact factor: 1.843

Review 6.  Effect of pulsed field ablation on solid tumor cells and microenvironment.

Authors:  Yujue Wang; Tian'an Jiang; Liting Xie; Huiyang Wang; Jing Zhao; Lei Xu; Chengyu Fang
Journal:  Front Oncol       Date:  2022-08-23       Impact factor: 5.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.